相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis
Soizic Guihard et al.
BLOOD (2010)
The mitogen-activated protein kinase signaling pathways: role in megakaryocyte differentiation
S. Severin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Genetic Demonstration of a Redundant Role of Extracellular Signal-Regulated Kinase 1 (ERK1) and ERK2 Mitogen-Activated Protein Kinases in Promoting Fibroblast Proliferation
Laure Voisin et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Tight control of MEK-ERK activation is essential in regulating proliferation, survival, and cytokine production of CD34+-derived neutrophil progenitors
Christian R. Geest et al.
BLOOD (2009)
Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation
Jing Zhang et al.
BLOOD (2009)
Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation
Alexandra Mazharian et al.
EXPERIMENTAL HEMATOLOGY (2009)
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Amit J. Sabnis et al.
PLOS BIOLOGY (2009)
Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway
Judith S. Sebolt-Leopold
CLINICAL CANCER RESEARCH (2008)
The N-Terminal Domain of ERK1 Accounts for the Functional Differences with ERK2
Matilde Marchi et al.
PLOS ONE (2008)
Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signal-regulated kinase signaling maintains hematopoietic repopulating activity of Lin- CD34+ CD133+ cord blood cells
Robert A. J. Oostendorp et al.
STEM CELLS (2008)
Activation of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment
Chia-Lin Hsu et al.
BLOOD (2007)
Endogenous K-ras signaling in erythroid differentiation
Jing Zhang et al.
CELL CYCLE (2007)
Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice
Chaitali Parikh et al.
CANCER RESEARCH (2007)
Raf kinases: Function, regulation and role in human cancer
Deborah T. Leicht et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Expression of oncogenic K-ras from its endogenous promoter leads to a partial block of erythroid differentiation and hyperactivation of cytokine-dependent signaling pathways
Jing Zhang et al.
BLOOD (2007)
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia
Chiara Gregorj et al.
BLOOD (2007)
K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cells
Margaret E. M. Van Meter et al.
BLOOD (2007)
Mek1/2 MAPK kinases are essential for mammalian development, homeostasis, and Raf-induced hyperplasia
Florence A. Scholl et al.
DEVELOPMENTAL CELL (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice
Chaitali Parikh et al.
BLOOD (2006)
Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo
Benjamin S. Braun et al.
BLOOD (2006)
Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis
Vickram Bissonauth et al.
DEVELOPMENT (2006)
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia
A Zebisch et al.
CANCER RESEARCH (2006)
Regulation and role of Raf-1/B-Raf heterodimerization
LK Rushworth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
P44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis.
C Bourcier et al.
CANCER RESEARCH (2006)
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
MJ Garnett et al.
MOLECULAR CELL (2005)
Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts
K Mercer et al.
CANCER RESEARCH (2005)
Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway
MB Miranda et al.
LEUKEMIA RESEARCH (2005)
Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
V Emuss et al.
CANCER RESEARCH (2005)
Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo
J Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Germline mutations in HRAS proto-oncogene cause Costello syndrome
Y Aoki et al.
NATURE GENETICS (2005)
The role of Erk1 and Erk2 in multiple stages of T cell development
AM Fischer et al.
IMMUNITY (2005)
Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemia
MR Ricciardi et al.
LEUKEMIA (2005)
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies
PM LoRusso et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A critical function for B-Raf at multiple stages of myelopoiesis
T Kamata et al.
BLOOD (2005)
Endogenous oncogenic K-rasG12D stimulates proliferation and widespread neoplastic and developmental defects
DA Tuveson et al.
CANCER CELL (2004)
Brief report - Raf-1 is not required for megakaryocytopoiesis or TPO-induced ERK phosphorylation
T Kamata et al.
BLOOD (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
LS Steelman et al.
LEUKEMIA (2004)
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder
BS Braun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors
J Zhang et al.
BLOOD (2004)
Targeting the mitogen-activated protein kinase cascade to treat cancer
JS Sebolt-Leopold et al.
NATURE REVIEWS CANCER (2004)
An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development
MK Saba-El-Leil et al.
EMBO REPORTS (2003)
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts
P Lunghi et al.
LEUKEMIA (2003)
Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitors
MA Morgan et al.
LEUKEMIA (2003)
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
C Guerra et al.
CANCER CELL (2003)
Mek2 is dispensable for mouse growth and development
LF Bélanger et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Raf proteins and cancer: B-Raf is identified as a mutational target
KE Mercer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2003)
Essential role for ERK2 mitogen-activated protein kinase in placental development
N Hatano et al.
GENES TO CELLS (2003)
Protein kinase C mediates mutant N-Ras-induced developmental abnormalities in normal human erythroid cells
RL Darley et al.
BLOOD (2002)
Regulation of Raf-Akt cross-talk
K Moelling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines
MB Miranda et al.
LEUKEMIA (2002)
ERK signalling and oncogene transformation are not impaired in cells lacking A-Raf
K Mercer et al.
ONCOGENE (2002)
Involvement of B-Raf in Ras-induced Raf-1 activation
S Mizutani et al.
FEBS LETTERS (2001)
Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf
BH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells
WL Blalock et al.
LEUKEMIA (2001)
Requirement of thrombopoietin-induced activation of ERK for megakaryocyte differentiation and of p38 for erythroid differentiation
R Miyazaki et al.
ANNALS OF HEMATOLOGY (2001)
MEK kinase activity is not necessary for Raf-1 function
M Hüser et al.
EMBO JOURNAL (2001)
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
M Mikula et al.
EMBO JOURNAL (2001)
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
G Pearson et al.
ENDOCRINE REVIEWS (2001)
Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling
MA Morgan et al.
BLOOD (2001)
Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development
LM Esteban et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons
S Wiese et al.
NATURE NEUROSCIENCE (2001)
Specificity and mechanism of action of some commonly used protein kinase inhibitors
SP Davies et al.
BIOCHEMICAL JOURNAL (2000)
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
M Kondo et al.
NATURE (2000)
MEK activity regulates negative selection of immature CD4+CD8+ thymocytes
U Bommhardt et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism
PE Hoyle et al.
LEUKEMIA (2000)
A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells
WL Blalock et al.
ONCOGENE (2000)
Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
CK Weber et al.
ONCOGENE (2000)
Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis
L Wojnowski et al.
MECHANISMS OF DEVELOPMENT (2000)
分享论文
